Allos Therapeutics Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 111

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 7

  • Investments
  • 1

Allos Therapeutics General Information

Description

Provider of small molecule therapeutics for the treatment of cancer. The company develops a folate analogue metabolic inhibitor.

Contact Information

Formerly Known As
HemoTech Sciences
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 11080 Circlepoint Road
  • Suite 200
  • Westminster, CO 80020
  • United States
+1 (303)
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 11080 Circlepoint Road
  • Suite 200
  • Westminster, CO 80020
  • United States
+1 (303)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allos Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Allos Therapeutics‘s full profile, request access.

Request a free trial

Allos Therapeutics Patents

Allos Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2011289638-A1 Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin Active 10-Aug-2010
AU-2011289638-B2 Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin Inactive 10-Aug-2010
CA-2807484-A1 Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin Inactive 10-Aug-2010
EP-2603082-A1 Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin Inactive 10-Aug-2010
EP-2603082-A4 Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin Inactive 10-Aug-2010 A61K31/519
To view Allos Therapeutics’s complete patent history, request access »

Allos Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allos Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Allos Therapeutics‘s full profile, request access.

Request a free trial

Allos Therapeutics Investments (1)

Allos Therapeutics’s most recent deal was a Corporate with N-Gene for . The deal was made on 15-Apr-2002.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
N-Gene 15-Apr-2002 Corporate Drug Discovery
To view Allos Therapeutics’s complete investments history, request access »

Allos Therapeutics FAQs

  • When was Allos Therapeutics founded?

    Allos Therapeutics was founded in 1992.

  • Where is Allos Therapeutics headquartered?

    Allos Therapeutics is headquartered in Westminster, CO.

  • What is the size of Allos Therapeutics?

    Allos Therapeutics has 111 total employees.

  • What industry is Allos Therapeutics in?

    Allos Therapeutics’s primary industry is Drug Discovery.

  • Is Allos Therapeutics a private or public company?

    Allos Therapeutics is a Private company.

  • What is the current valuation of Allos Therapeutics?

    The current valuation of Allos Therapeutics is .

  • What is Allos Therapeutics’s current revenue?

    The current revenue for Allos Therapeutics is .

  • How much funding has Allos Therapeutics raised over time?

    Allos Therapeutics has raised $175M.

  • Who are Allos Therapeutics’s investors?

    Abingworth, Aisling Capital, Invesco, Johnson & Johnson JJDC, and Marquette Venture Partners are 5 of 11 investors who have invested in Allos Therapeutics.

  • When was Allos Therapeutics acquired?

    Allos Therapeutics was acquired on 05-Sep-2012.

  • Who acquired Allos Therapeutics?

    Allos Therapeutics was acquired by Spectrum Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process